| 1. | Charman SC, Sharples LD, McNeil KD, Wallwork J. Assessment of survival benefit after lung transplantation by patient diagnosis. J Heart Lung Transplant 2002;21:226–232. |
| 2. | Zuckerman JB, Kotloff RM. Lung transplantation for cystic fibrosis [review]. Clin Chest Med 1998;19:535–554, vii. |
| 3. | Kerem E, Reisman J, Corey M, Canny GJ, Levison H. Prediction of mortality in patients with cystic fibrosis. N Engl J Med 1992;326:1187–1191. |
| 4. | Arcasoy SM, Kotloff RM. Lung transplantation. N Engl J Med 1999;340:1081–1091. |
| 5. | Geller DE, Kaplowitz H, Light MJ, Colin AA; Scientific Advisory Group, Investigators, and Coordinators of the Epidemiologic Study of Cystic Fibrosis. Allergic bronchopulmonary aspergillosis in cystic fibrosis: reported prevalence, regional distribution, and patient characteristics. Chest 1999;116:639–646. |
| 6. | Hosenpud JD, Bennett LE, Keck BM, Edwards EB, Novick RJ. Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease. Lancet 1998;351:24–27. |
| 7. | Liou TG, Adler FR, Cahill BC, FitzSimmons SC, Huang D, Hibbs JR, Marshall BC. Survival effect of lung transplantation among patients with cystic fibrosis. JAMA 2001;286:2683–2689. |
| 8. | Liou TG, Adler FR, Huang D. Use of lung transplantation survival models to refine patient selection in cystic fibrosis. Am J Respir Crit Care Med 2005;171:1053–1059. |
| 9. | Mayer-Hamblett N, Rosenfeld M, Emerson J, Goss CH, Aitken ML. Developing cystic fibrosis lung transplant referral criteria using predictors of 2-year mortality. Am J Respir Crit Care Med 2002;166:1550–1555. |
| 10. | Belkin RA, Singer LG, Henig NR. Height, Aspergillus and MRSA: potential predictors of death in CF patients on the lung transplant waiting list [abstract]. Pediatr Pulmonol 2001;32:317. |
| 11. | Belkin RAB, Singer LG, Rubenstein RC, Xie SX, Kotloff RM, Lipson DA, Henig NR. Elevated PaCO2 as a risk factor for death in CF patients awaiting lung transplantation [abstract]. Pediatr Pulmonol 2004;38(Suppl. 27):317. |
| 12. | Collett D. Informative censoring. In: Collett D, editor. Modelling survival data in medical research. London: Chapman & Hall; 2003. p. 319. |
| 13. | Liou TG, Adler FR, Fitzsimmons SC, Cahill BC, Hibbs JR, Marshall BC. Predictive 5-year survivorship model of cystic fibrosis. Am J Epidemiol 2001;153:345–352. |
| 14. | Vizza CD, Yusen RD, Lynch JP, Fedele F, Alexander Patterson G, Trulock EP. Outcome of patients with cystic fibrosis awaiting lung transplantation. Am J Respir Crit Care Med 2000;162:819–825. |
| 15. | Yankaskas JR, Mallory GB Jr. Lung transplantation in cystic fibrosis: consensus conference statement. Chest 1998;113:217–226. |
| 16. | Maurer JR, Frost AE, Estenne M, Higenbottam T, Glanville AR; International Society for Heart and Lung Transplantation, American Thoracic Society, American Society of Transplant Physicians, European Respiratory Society. International guidelines for the selection of lung transplant candidates. J Heart Lung Transplant 1998;17:703–709. |
| 17. | United Network for Organ Sharing. Organ distribution. Richmond, VA: United Network for Organ Sharing; 2004. Policies 3.5–3.9. Available from: http://www.unos.org/policiesandbylaws/policies.asp?resources=true (accessed January 6, 2006). |
| 18. | Kotloff RM, Zuckerman JB. Lung transplantation for cystic fibrosis: special considerations. Chest 1996;109:787–798. |
| 19. | Milla CE, Warwick WJ. Risk of death in cystic fibrosis patients with severely compromised lung function. Chest 1998;113:1230–1234. |
| 20. | Doershuk CF, Stern RC. Timing of referral for lung transplantation for cystic fibrosis: overemphasis on FEV1 may adversely affect overall survival. Chest 1999;115:782–787. |
| 21. | American Thoracic Society. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;166:111–117. |
| 22. | Kadikar A, Maurer J, Kesten S. The six-minute walk test: a guide to assessment for lung transplantation. J Heart Lung Transplant 1997;16:313–319. |
| 23. | Nixon PA, Orenstein DM, Kelsey SF, Doershuk CF. The prognostic value of exercise testing in patients with cystic fibrosis. N Engl J Med 1992;327:1785–1788. |
| 24. | Sharma R, Florea VG, Bolger AP, Doehner W, Florea ND, Coats AJ, Hodson ME, Anker SD, Henein MY. Wasting as an independent predictor of mortality in patients with cystic fibrosis. Thorax 2001;56:746–750. |
| 25. | McAllister TA, Mocan H, Murphy AV, Beattie TJ. Antibiotic susceptibility of staphylococci from CAPD peritonitis in children. J Antimicrob Chemother 1987;19:95–100. |
| 26. | Egan TM, Bennett LE, Garrity ER, Grover FL, Ring WS, Robbins RC, Trulock E, Wood DE. Predictors of death on the UNOS lung transplant waiting list: results of a multivariate analysis. J Heart Lung Transplant 2001;20:242. |
| 27. | Hayllar KM, Williams SG, Wise AE, Pouria S, Lombard M, Hodson ME, Westaby D. A prognostic model for the prediction of survival in cystic fibrosis. Thorax 1997;52:313–317. |
| 28. | Augarten A, Akons H, Aviram M, Bentur L, Blau H, Picard E, Rivlin J, Miller MS, Katznelson D, Szeinberg A, et al. Prediction of mortality and timing of referral for lung transplantation in cystic fibrosis patients. Pediatr Transplant 2001;5:339–342. |
| 29. | Rosenecker J, Hofler R, Steinkamp G, Eichler I, Smaczny C, Ballmann M, Posselt HG, Bargon J, von der Hardt H. Diabetes mellitus in patients with cystic fibrosis: the impact of diabetes mellitus on pulmonary function and clinical outcome. Eur J Med Res 2001;6:345–350. |
| 30. | Ledson MJ, Gallagher MJ, Jackson M, Hart CA, Walshaw MJ. Outcome of Burkholderia cepacia colonisation in an adult cystic fibrosis centre. Thorax 2002;57:142–145. |
| 31. | Frangolias DD, Mahenthiralingam E, Rae S, Raboud JM, Davidson AG, Wittmann R, Wilcox PG. Burkholderia cepacia in cystic fibrosis: variable disease course. Am J Respir Crit Care Med 1999;160:1572–1577. |
| 32. | Davis PB. Clinical pathophysiology and manifestations of lung disease. In: Yankaskas JR, Knowles MR, editors. Cystic fibrosis in adults. Philadelphia, PA: Lippincott-Raven; 1999. pp. 45–67. |
| 33. | Demko CA, Byard PJ, Davis PB. Gender differences in cystic fibrosis: Pseudomonas aeruginosa infection. J Clin Epidemiol 1995;48:1041–1049. |
| 34. | Goss CH, Otto K, Aitken ML, Rubenfeld GD. Detecting Stenotrophomonas maltophilia does not reduce survival of patients with cystic fibrosis. Am J Respir Crit Care Med 2002;166:356–361. |
| 35. | Schaedel C, de Monestrol I, Hjelte L, Johannesson M, Kornfalt R, Lindblad A, Strandvik B, Wahlgren L, Holmberg L. Predictors of deterioration of lung function in cystic fibrosis. Pediatr Pulmonol 2002;33:483–491. |
| 36. | Huang NN, Schidlow DV, Szatrowski TH, Palmer J, Laraya-Cuasay LR, Yeung W, Hardy K, Quitell L, Fiel S. Clinical features, survival rate, and prognostic factors in young adults with cystic fibrosis. Am J Med 1987;82:871–879. |
| 37. | Rosenfeld M, Davis R, FitzSimmons S, Pepe M, Ramsey B. Gender gap in cystic fibrosis mortality. Am J Epidemiol 1997;145:794–803. |
| 38. | Lewis P. CF epidemiology: population perspective and impact [Symposium Session Summaries]. Annual North American Cystic Fibrosis Conference, 2000. |
| 39. | Gaskin K, Gurwitz D, Durie P, Corey M, Levison H, Forstner G. Improved respiratory prognosis in patients with cystic fibrosis with normal fat absorption. J Pediatr 1982;100:857–862. |
| 40. | Schechter MS, Shelton BJ, Margolis PA, Fitzsimmons SC. The association of socioeconomic status with outcomes in cystic fibrosis patients in the United States. Am J Respir Crit Care Med 2001;163:1331–1337. |
| 41. | Fraser KL, Tullis DE, Sasson Z, Hyland RH, Thornley KS, Hanly PJ. Pulmonary hypertension and cardiac function in adult cystic fibrosis: role of hypoxemia. Chest 1999;115:1321–1328. |
| 42. | Corey M, McLaughlin FJ, Williams M, Levison H. A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto. J Clin Epidemiol 1988;41:583–591. |
| 43. | Walters S, Britton J, Hodson ME. Hospital care for adults with cystic fibrosis: an overview and comparison between special cystic fibrosis clinics and general clinics using a patient questionnaire. Thorax 1994;49:300–306. |
| 44. | Beker LT, Russek-Cohen E, Fink RJ. Stature as a prognostic factor in cystic fibrosis survival. J Am Diet Assoc 2001;101:438–442. |
